Cargando…
A platelet protein biochip rapidly detects an Alzheimer’s disease-specific phenotype
Alzheimer’s disease (AD), a multifactorial neurodegenerative condition caused by genetic and environmental factors, is diagnosed using neuropsychological tests and brain imaging; molecular diagnostics are not routinely applied. Studies have identified AD-specific cerebrospinal fluid (CSF) biomarkers...
Autores principales: | Veitinger, Michael, Oehler, Rudolf, Umlauf, Ellen, Baumgartner, Roland, Schmidt, Georg, Gerner, Christopher, Babeluk, Rita, Attems, Johannes, Mitulovic, Goran, Rappold, Eduard, Lamont, John, Zellner, Maria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4201753/ https://www.ncbi.nlm.nih.gov/pubmed/25248508 http://dx.doi.org/10.1007/s00401-014-1341-8 |
Ejemplares similares
-
Platelets, a reliable source for peripheral Alzheimer’s disease biomarkers?
por: Veitinger, Michael, et al.
Publicado: (2014) -
Careful neuropsychological testing reveals a novel genetic marker, GSTO1*C, linked to the pre-stage of Alzheimer's disease
por: Umlauf, Ellen, et al.
Publicado: (2016) -
A Practical and Analytical Comparative Study of Gel-Based Top-Down and Gel-Free Bottom-Up Proteomics Including Unbiased Proteoform Detection
por: Ercan, Huriye, et al.
Publicado: (2023) -
Biochips: technology and applications
por: Xing, Wan-Li, et al.
Publicado: (2003) -
Implication of Biochips in Tuberculosis Diagnostics
por: Zimenkov,, D.V., et al.
Publicado: (2011)